Glucose-lowering Drugs as an Adjunct to Insulin Therapy in Chinese Patients With Type 1 Diabetes
NCT07415226
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
500
Enrollment
OTHER
Sponsor class
Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG:
GLD+insulin group
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine